USFDA grants approval of Bkemv to Amgen EP News Bureau May 29, 2024 Bkemv is the first interchangeable biosimilar to Soliris to treat certain rare diseases
USV and Biogenomics launches Insuquick EP News Bureau Dec 20, 2023 Insuquick is a “Make in India” product and is available in all metros, and tier I/II cities
Biocon Biologics successfully integrates acquired biosimilars business across 120 countries EP News Bureau Dec 19, 2023 Over 10 emerging markets along with Japan, Australia and New Zealand have transitioned in this final phase of the integration of…
USV, Biogenomics launch INSUQUICK, biosimilar Insulin Aspart for diabetes treatment EP News Bureau Nov 9, 2023 Insuquick will be available in cartridges, vials, and prefilled disposable pens
EMA accepts Intas Pharma’s MAA for DMB-3115 EP News Bureau Jul 14, 2023 herapeutic equivalence and safety confirmed between DMB-3115 and Stelara in global phase III
Dr Reddy’s completes Phase I study of DRL_TC, a tocilizumab biosimilar candidate EP News Bureau Jun 5, 2023 This Phase I study used an intravenous (IV) formulation to evaluate the pharmacokinetic equivalence, safety and immunogenicity of…
Biocon Biologics, Viatris get EC approval for biosimilar Bevacizumab EP News Bureau Apr 26, 2021 Abevmy 100 and 400 mg is approved for the treatment of metastatic colorectal carcinoma, metastatic breast cancer, non small-cell…
USFDA defers action on BLA for Avastin biosimilar, notifies Biocon Biologics, Mylan EP News Bureau Dec 25, 2020 To complete the application, the agency noted that an inspection of the manufacturing facility is required as a part of the…
Biocon and Voluntis deal to transform insulin biosimilars personalised care through digital… EP News Bureau Jul 30, 2020 By the end of March 2020, Semglee was approved in 60 countries and launched in several countries including the EU, Australia and…
‘Lupin has gained significant momentum towards development of biosimilar products with primary… Lakshmipriya Nair Dec 4, 2019 Lupin Biotech, with a new-age R&D facility in Pune, is developing and commercialising biosimilars globally. The successful…